Track market-moving stories before they get noisy

Resources Investor Relations Journalists Agencies Client Login Send a Release News Products Contact , /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Viking Therapeutics, Inc. (NASDAQ: VKTX) breached their fiduciary duties to shareholders.  The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms.

If you are a long-term VKTX stockholder please contact Sophia Anne Silayan by email at [email protected] or call (833) 672-0814.  The consultation and case are free with no obligation to you.  Kuehn Law pays all case costs and does not charge its investor clients. Shareholders should contact the firm immediately as there may be limited time to enforce your rights. 

Why Your Participation Matters:

As a shareholder your voice matters, and by getting involved, you contribute to the integrity and fairness of the financial markets. Your investment. Your voice. Your future.™ 

For additional information, please visit Shareholder Derivative Litigation - Kuehn Law.

Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts:
Kuehn Law, PLLC
Justin Kuehn, Esq.
53 Hill Street, Suite 605
Southampton, NY 11968
[email protected]
(833) 672-0814

SOURCE Kuehn Law, PLLC

Also from this source

This news release constitutes a “designated news release” for the purposes of the prospectus supplement dated January 12, 2026 to the short form base shelf prospectus of Brookfield Renewable Corporation and Brookfield Renewable Partners L.P.

BROOKFIELD, News, July 21, 2026 (GLOBE NEWSWIRE) -- Brookfield Renewable Partners L.P. (NYSE: BEP; TSX: BEP.UN) (“BEP”) and Brookfield Renewable Corporation (NYSE: BEPC; TSX: BEPC) (“BEPC”, and together with BEP, “Brookfield Renewable”) today announced that it has approved plans to simplify its corporate structure (the “Simplification”) by converting BEP and BEPC into one publicly traded corporation, Brookfield Renewable Partners Inc. (“BEP Inc.”).  

“We are pleased to take this important step in the evolution of Brookfield Renewable,” said Connor Teskey, Chief Executive Officer of Brookfield Renewable. “By simplifying our corporate structure, we expect to enhance the accessibility of our securities to a broader range of investors, support increased index demand and provide a traditional corporate ownership structure. We believe this transaction will strengthen our position over the long term and create lasting value for our investors.”

Benefits of a Simplified Structure

Brookfield Renewable expects the Simplification to be tax-deferred for Canadian and U.S. investors and completed without any meaningful cost to the business, while providing securityholders with the following benefits, among others:

Improved consolidated trading liquidity through a single listed security;Increased demand from current indices and potential additional index inclusion;Stronger alignment with long-term capital allocation trends toward indexable and ETF-eligible corporate securities;Simplified investor analysis, screening, and benchmarking through a single listed reporting entity;Broader access to a larger pool of investors who prefer corporate structures;Enhanced governance framework and voting rights for public securityholders; andFor BEP unitholders, elimination of onerous partnership tax reporting forms and preferential dividend tax rates for many Canadian and U.S. taxable investors. Corporate Simplification Details

Under the terms of the Simplification, upon receipt of approval from BEP unitholders, all outstanding limited partnership units of BEP, other than preferred units, will, together with certain related exchangeable securities, be exchanged on a one-for-one basis for newly issued shares of BEP Inc.

BEPC shareholders will separately be asked to approve the Simplification, pursuant to which their class A exchangeable subordinate voting shares in BEPC (the “BEPC exchangeable shares”) will be exchanged for new shares of BEP Inc. on a one-for-one basis. If BEPC shareholders vote in favor of the Simplification, the exchange can also be completed on a tax-deferred basis. If BEPC shareholders do not approve the Simplification, the BEPC exchangeable shares will remain outstanding and become exchangeable, on a one-for-one basis, for newly issued shares of BEP Inc., rather than being exchangeable for units of BEP as they are today.

Completion of the exchange of BEP limited partnership units for shares of BEP Inc. is not conditional on BEPC shareholder approval.

Special meetings of BEP unitholders and BEPC shareholders will be held on October 14, 2026, and securityholders of record as of the close of business on August 21, 2026 will be entitled to vote at the applicable meeting. The Simplification will be implemented by way of a court-approved plan of arrangement and will be subject to customary regulatory approvals for a transaction of this nature, including approval for the listing of BEP Inc.’s shares on the New York Stock Exchange and Toronto Stock Exchange. Following securityholder approval, Brookfield Renewable expects to complete the Simplification in the fourth quarter of 2026.

There will be no change to Brookfield’s ownership of Brookfield Renewable as a result of the Simplification. BEP’s preferred units and public debt will remain outstanding and unaffected by the Simplification.

Brookfield Asset Management’s management fee and incentive distribution arrangements will continue in a manner consistent with Brookfield Renewable’s existing arrangements.

The Board of Directors of each of BEP and BEPC, based in part on the unanimous recommendations of their respective nominating and governance committees (consisting entirely of independent directors) and the fairness opinions received from Scotiabank, unanimously determined that the Simplification is in the best interests of BEP and BEPC, respectively, and have unanimously resolved to approve the Simplification and recommend that BEP unitholders and BEPC shareholders vote in favor of the Simplification.

Torys LLP is acting as legal advisor to Brookfield Renewable for the Simplification.

Scotiabank is acting as independent financial advisor and Goodmans LLP is acting as independent legal counsel to the nominating and governance committees of each of BEP and BEPC in connection with the Simplification.

Further information regarding the Simplification, including details on the votes that will be required and the other conditions for closing, will be contained in a joint management information circular of BEP and BEPC.

Copies of the joint management information circular, the arrangement agreement, the plan of arrangement and certain related documents will be filed with the applicable Canadian securities regulators and with the United States Securities and Exchange Commission and will be available on SEDAR+ at https://sedarplus.ca and on EDGAR at https://sec.gov.

About Brookfield Renewable

Brookfield Renewable operates one of the world’s largest publicly traded platforms for renewable power and sustainable solutions. Our renewable power portfolio consists of hydroelectric, wind, utility-scale solar, distributed solar and storage facilities and our sustainable solutions assets include our investment in a leading global nuclear services business and a portfolio of investments in carbon capture and storage capacity, agricultural renewable natural gas, materials recycling and eFuels manufacturing capacity, among others.

Investors can access the portfolio either through Brookfield Renewable Partners L.P. (NYSE: BEP; TSX: BEP.UN), a Bermuda-based limited partnership, or Brookfield Renewable Corporation (NYSE, TSX: BEPC), a Canadian corporation. Further information is available at https://bep.brookfield.com.

Brookfield Renewable is the flagship listed energy company of Brookfield Asset Management, a leading global alternative asset manager headquartered in New York, with over $1 trillion of assets under management. For more information, go to https://brookfield.com.

Contact Information

This news release does not constitute an offer to sell or a solicitation of an offer to buy any securities and shall not constitute an offer, solicitation or sale in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful. Any securities to be issued in the transaction will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or the securities laws of any state of the United States, and any securities issued in connection with the transaction are anticipated to be issued in reliance upon the exemption from the registration requirements of the U.S. Securities Act provided for by Section 3(a)(10) thereof and in accordance with applicable state securities laws.

Cautionary Statement Regarding Forward-looking Statements

This news release may contain “forward-looking information” within the meaning of Canadian securities laws and “forward-looking statements” within the meaning of applicable U.S. securities laws. The words “will”, “target”, “future”, “growth”, “expect”, “believe”, “may”, derivatives thereof and other expressions which are predictions of or indicate future events, trends or prospects and which do not relate to historical matters, identify the above mentioned and other forward-looking statements. Forward-looking statements or information in this news release include statements with respect to the Simplification and the special meetings of the unitholders of BEP and the shareholders of BEPC.

Although Brookfield Renewable believes that these forward-looking statements and information are based upon reasonable assumptions and expectations, the reader should not place undue reliance on them, or any other forward-looking statements or information in this news release. The future performance and prospects of Brookfield Renewable, and the completion of the Simplification, are subject to a number of known and unknown risks and uncertainties, which could cause actual results to differ materially from those contemplated or implied by the forward-looking statements or information in this news release. Such risks and factors are described in the documents filed by Brookfield Renewable with the securities regulators in Canada and the United States including under “Risk Factors” in the most recent Annual Report on Form 20-F of BEP and in the most recent Annual Report on Form 20-F of BEPC, and other risks and factors that are described therein. Certain risks and uncertainties specific to the proposed Simplification will be further described in the joint management information circular of BEP and BEPC to be delivered to security holders in advance of the special meetings. Except as required by law, Brookfield Renewable undertakes no obligation to publicly update or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise.

Any statements contained herein with respect to tax consequences are of a general nature only and are not intended to be, nor should they be construed to be, legal or tax advice to any person, and no representation with respect to tax consequences is made. Unitholders and shareholders are urged to consult their tax advisors with respect to their particular circumstances.

Pendle, the yield tokenization protocol that lets traders split and trade future yield, has crossed $111M in total value locked on the Monad blockchain. That makes it the fifth-largest protocol on the chain, less than a month after launching there on June 19.

The growth engine behind the numbers is AUSD, the Agora Dollar stablecoin backed 1:1 by cash, US Treasury bills, and repos. AUSD supply on Monad has ballooned to roughly $115M, making it the second-largest stablecoin on the chain behind USDC.

From zero to $111M in under a month Pendle hit approximately $51M in TVL within its first 10 days on Monad, then more than doubled. Pendle currently runs at least three active markets on Monad, all built around AUSD and its yield-bearing cousin, earnAUSD. The maturities on these markets cluster around October 8, 2026, giving traders a defined window to speculate on or lock in yields.

Advertisement

Pendle’s Monad deployment has processed over $52M in trading volume over the past 30 days.

Pendle works by taking yield-bearing assets and splitting them into two tokens. One represents the principal, the other represents the future yield. Traders can sell their future interest payments to someone else today, or buy someone else’s future yield at a discount.

The incentive machine behind the growth Pendle’s Monad expansion has been turbocharged by weekly liquidity incentives of up to $75,000 for AUSD liquidity on the platform, roughly $300K per month in direct subsidies flowing to liquidity providers.

Pendle’s recent integration with Aave v3 pulled in more than $75M in deposits within the first 24 hours.

Across all chains, Pendle’s ecosystem now holds more than $1.14B in total value locked. The Monad deployment, at $111M, represents roughly 10% of that total.

The PENDLE token itself trades around $1.64, giving it a market cap of approximately $281.55M.

Disclosure: This article was edited by Editorial Team. For more information on how we create and review content, see our Editorial Policy.

Asher Genoot, Hut 8 CEO, joins 'Power Lunch' to discuss the company's latest hyperscaler deal, the impact to lower power grids and much more.

IRVINE, Calif.--(BUSINESS WIRE)--Viant Technology Inc. (Nasdaq: DSP), a leader in CTV and AI-powered programmatic advertising, today announced that members of its management team are scheduled to participate in upcoming investor conferences.Event details are as follows:D.A. Davidson Small Cap ConferenceAugust 11thVirtualCanaccord Genuity Annual Growth ConferenceAugust 12th (Fireside chat at 9:00 am - 9:25 am ET)Boston, MACannonball Research ConferenceAugust 13th (Fireside chat at 1:00 pm - 2:00.

WASHINGTON--(BUSINESS WIRE)--CAVA Group, Inc. (NYSE: CAVA), the category-defining Mediterranean fast-casual restaurant brand that brings heart, health, and humanity to food, will host a conference call on Tuesday, August 11, 2026 at 5:00 PM Eastern Time to discuss second quarter 2026 financial results and provide a business update. A press release with second quarter financial results will be issued at approximately 4:10 PM Eastern Time on Tuesday, August 11, 2026. The call will be webcast live.

- Atebimetinib showed broad antitumor activity across KRAS-, NRAS-, and BRAF-mutant models, including colorectal, lung, and melanoma, by resisting the RAF-mediated bypass signaling that has constrained other MEK inhibitors -

- In head-to-head in vivo studies, atebimetinib produced deeper, more durable tumor growth inhibition than the FDA-approved MEK inhibitor binimetinib -

- Atebimetinib was associated with favorable tolerability in preclinical models, consistent with Deep Cyclic Inhibitor technology’s design to decouple antitumor activity from the toxicity of continuous MAPK suppression -

- In a preclinical cancer cachexia model, atebimetinib-treated animals sustained body weight near baseline through approximately two weeks of dosing, while untreated controls lost a median of more than 20% of body weight -

NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a late-stage clinical oncology company focused on keeping cancer patients alive and helping them thrive, today announced the publication of new findings in Cancer Research, a leading peer-reviewed journal of the American Association for Cancer Research, characterizing the differentiated mechanism and broad preclinical activity of atebimetinib.

The article, “Dual-MEK Inhibitor Atebimetinib Displays Broad Activity in RAS- and RAF-Mutant Tumors via Deep Cyclic Inhibition and Resisting RAF-Bypass,” (Kolitz et al., Cancer Research, doi.org/10.1158/0008-5472.CAN-25-4907) reports that atebimetinib demonstrated broad antitumor activity across RAS- and RAF-mutant models while resisting RAF-mediated bypass signaling, a key mechanism associated with resistance to other MEK inhibitors. Because the activity observed spanned a range of KRAS, NRAS, and BRAF alterations, the findings support the potential of atebimetinib to address RAS- and RAF-mutant cancers broadly — including the majority of RAS-mutant tumors that are not addressed by currently available mutation-selective inhibitors.

“Atebimetinib was deliberately designed to overcome the historical limitations of MEK inhibition, including the toxicity that comes with chronic MAPK pathway suppression, and the RAF-mediated pathway reactivation that has limited the durability of pathway suppression, particularly in RAS-mutant disease,” said Brett Hall, Ph.D., Chief Scientific Officer of Immuneering. “The new findings noted in the Cancer Research article underscore the scientific basis for our Deep Cyclic Inhibitor technology and the broad, mutation-agnostic, durable activity we observed across RAS- and RAF-mutant models, reinforcing atebimetinib's position as a differentiated, modern MEK inhibitor.”

The article describes how atebimetinib combines a novel dual-MEK mechanism with a short half-life designed to achieve Deep Cyclic Inhibition (DCI) of the MAPK pathway. Unlike other MEK inhibitors that chronically suppress signaling and are prone to RAF-mediated bypass, atebimetinib was shown to produce profound but transient inhibition of MAPK signaling followed by recovery periods that allow normal tissue to rest between doses – an approach designed to improve tolerability while maintaining antitumor activity.

Key findings include:

Atebimetinib demonstrated potent inhibition of both pERK and pMEK across multiple KRAS-, NRAS-, and BRAF-mutant tumor models, including colorectal, lung, and melanoma models.Whereas other MEK inhibitors reduced pERK but allowed pMEK to accumulate — the molecular signature of RAF-mediated pathway reactivation — atebimetinib reduced both pERK and pMEK, reflecting its resistance to CRAF-mediated bypass.Atebimetinib’s short half-life enabled deep cyclic inhibition of the MAPK pathway, characterized by deep suppression during peak exposure followed by recovery toward physiologic baseline signaling between doses.In multiple head-to-head in vivo studies, atebimetinib demonstrated greater depth and durability of tumor growth inhibition than the FDA-approved MEK inhibitor binimetinib across KRAS-, NRAS-, and BRAF-mutant tumor models while remaining well tolerated.In the Colon-26 model, a syngeneic colon-carcinoma model widely used to study cancer cachexia, atebimetinib-treated animals maintained body weight near baseline (within approximately 5%) through roughly two weeks of dosing, while untreated control animals lost a median of more than 20% of body weight by approximately day 14. Across the in vivo models more broadly, atebimetinib-treated mice maintained body weight within a median of 3-5% over up to four weeks of chronic dosing. Immuneering is currently recruiting patients in MAPKeeper 301 (NCT07562152), a global randomized Phase 3 pivotal trial evaluating atebimetinib plus mGnP versus standard-of-care gemcitabine/nab-paclitaxel in first-line metastatic pancreatic cancer. In the second half of the year, the company expects to dose the first patient in a Phase 2 trial of atebimetinib plus Libtayo® (cemiplimab) in patients with first-line RAS-mutant non-small cell lung cancer.

About Immuneering
Immuneering is a late-stage clinical oncology company dedicated to keeping cancer patients alive and helping them thrive, with an initial focus on patients with RAS, RAF, and other MAPK-driven cancers. The Company is developing an entirely new category of cancer medicines, Deep Cyclic Inhibitors, designed to improve overall survival by three mechanisms: shrinking tumors durably with less resistance, preserving body mass by countering cachexia, and minimizing side effects to maximize performance status and combinability. Immuneering’s lead product candidate, atebimetinib, is an investigational, oral, once-daily Deep Cyclic Inhibitor of MEK, designed to improve survival across many cancer indications. The company is conducting a global randomized pivotal trial, MAPKeeper 301, evaluating atebimetinib in combination with chemotherapy in first-line pancreatic cancer patients. The Company’s development pipeline also includes additional combination opportunities and preclinical stage programs. For more information, please visit www.immuneering.com.

Forward-Looking Statements
This press release contains forward-looking statements, including within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including, without limitation, statements regarding: the treatment potential of atebimetinib, alone or in combination with other agents to treat cancer, including modified Gemcitabine/nab-paclitaxel (mGnP) in first-line pancreatic cancer and its potential to deliver overall survival with both durability and tolerability; the timing of dosing of the MAPKeeper 301 study and the Phase 2 study in combination with Libtayo®; the ability of the three design mechanisms of atebimetinib to shrink tumors durably, improve overall survival and overcome the limitations of conventional MAPK inhibition and provide a more sustained clinical benefit for patients.

These forward-looking statements are based on management’s current expectations. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, the following: the risks inherent in oncology drug research and development, including target discovery, target validation, lead compound identification, and lead compound optimization; we have incurred significant losses, are not currently profitable and may never become profitable; our projected cash runway; our need for additional funding; our unproven approach to therapeutic intervention; our ability to address regulatory questions and the uncertainties relating to regulatory filings, reviews and approvals; the lengthy, expensive, and uncertain process of clinical drug development, including potential delays in activating trial sites or enrolling trial participants, or failure to obtain regulatory approvals; our reliance on third parties and collaborators to conduct our clinical trials, manufacture our product candidates, and develop and commercialize our product candidates, if approved; failure to compete successfully against other drug companies; protection of our proprietary technology and the confidentiality of our trade secrets; potential lawsuits for, or claims of, infringement of third-party intellectual property or challenges to the ownership of our intellectual property; our patents being found invalid or unenforceable; costs and resources of operating as a public company; and unfavorable or no analyst research or reports.

These and other important factors discussed under the caption “Risk Factors” in our Quarterly Report on Form 10-Q for the period ended December 31, 2025, and our other reports filed with the U.S. Securities and Exchange Commission, could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent management's estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, except as required by law, we disclaim any obligation to do so, even if subsequent events cause our views to change. These forward-looking statements should not be relied upon as representing our views as of any date subsequent to the date of this press release.

Investor Contact:
Laurence Watts
[email protected]

Media Contact:
David Caouette
[email protected]

Table of contents

The race among crypto platforms to offer U.S. stock trading is no longer about novelty. It is a structural pivot driven by a weakening crypto wealth effect and the search for assets with firmer fundamental ground. Yet behind the headlines, a critical divide is taking shape: are users buying tokenized price exposure, or do they hold actual shares with dividends, voting rights, and regulatory guardrails? In a conversation with BIT’s Head of Brokerage, Elio Cui laid out why this distinction matters and what it signals about the next era of crypto finance.

Why Exchanges Are Chasing U.S. Equities Cui identifies three forces pushing platforms toward stocks. First, the wealth effect that once supercharged crypto trading volumes has cooled. Liquidity is migrating, and platforms need new magnets to retain user capital. Second, high-conviction U.S. equities—particularly AI and commercial-space names—offer narratives anchored in productivity gains, not just speculation. For a generation of traders accustomed to chasing themes, those stocks are a natural next frontier. Third, the old model of growing through high-turnover crypto trading alone no longer delivers the same upside. Brokers and asset managers are being forced to rethink how they provide asset access, shifting from a purely crypto menu to a multi-asset one.

The shift is also a defensive move. When users can allocate to Nvidia or SpaceX-linked names through a familiar interface without leaving the crypto ecosystem, platforms become sticky. The question is not whether to offer stocks, but how.

Tokenized Exposure vs. Direct Ownership Many exchanges first reached into equities through tokenized stocks, CFDs, or synthetic products. These instruments replicate price action without requiring actual settlement or custody of the underlying securities. For platforms, they fit neatly into existing trading engines and revenue structures built on order books and market making. But as Cui argues, the model has a hard ceiling. Liquidity is shallow, pricing can drift from the reference market, and users end up holding a derivative claim rather than a real asset. If the issuer runs into trouble, the investor may be left with a contractual claim, not a legally segregated security.

BIT chose a heavier path when it launched U.S. stock trading in February: direct brokerage access with real holdings. That means trades settle with a U.S. clearing broker, dividends flow to the client, and assets sit inside a regulatory framework that separates client property from the platform’s balance sheet. The approach is slower to build—it requires licenses, broker-dealer relationships, KYC/AML pipes, and tax infrastructure—but it delivers what the tokenized model cannot: ownership, not just a price ticker. Even as the broader tokenized real-world asset (RWA) market has surpassed $20 billion on-chain, tokenized equities remain a niche precisely because investors are unwilling to accept imperfect pricing and unclear asset rights.

Behind the user-facing simplicity of buying a U.S. stock with stablecoins sits a complex compliance stack. BIT routes through a licensed entity in Bhutan that connects to a U.S. broker-dealer responsible for execution, clearing, and custody. An omnibus account structure keeps client information inside the licensed entity while trade execution, asset segregation, and settlement occur within the U.S. regulatory perimeter. Most client cash exposure and securities ultimately reside inside the U.S. clearing system, Cui explained, not on the platform’s own books.

The arrangement also involves a fiat-stablecoin conversion layer that incurs a cost—between 0.06% and 0.2%—charged by the licensed OTC provider. While modest, it is a reminder that bridging crypto and TradFi carries real operational friction. The infrastructure investment is significant enough that smaller platforms struggle to build it, while larger exchanges may be reluctant to cannibalize a trading model that already works for them. The compliance push unfolds as U.S. lawmakers and banking interests remain locked in a tug-of-war over a landmark crypto bill that faced last-minute opposition just before a Senate vote, underscoring the uncertain regulatory backdrop for any platform operating across jurisdictions.

The Investor Mindset and What Comes After the Bubble Cui’s observations point to a broader psychological shift among crypto natives. Traditional equity investors tend to value assets through cash flows, growth trajectories, and governance—a longer-horizon lens. Crypto users, by contrast, have been conditioned to chase narratives, monitor charts, and deploy leverage for amplified returns. Since launching the U.S. equities business, BIT has recorded almost no net outflows, a sign that capital is not just dipping in but staying. The move is not merely a product addition; it reflects what Cui describes as an industry gradually adopting value-investing logic as the easy growth of previous cycles fades.

BIT’s own rebranding in 2026—from Matrixport to BIT—mirrors this transition. The platform that began life as a crypto asset manager now positions itself as a global financial services bridge, connecting on-chain stablecoins with off-chain regulated broker-dealers. It is a signal that the boundary between crypto and traditional finance is blurring not just in rhetoric, but in infrastructure. For investors who have ridden multiple boom-and-bust cycles, the practical takeaway is unvarnished: holding a concentrated position in a core asset over time often outperforms the emotional cost of constant trading, even if it lacks the adrenaline of a 10x rally.

AUTHOR

With over five years of experience in crypto, blockchain, and tech content, Ishtiyaq makes complex topics easy to understand. He simplifies blockchain and digital currency concepts for a wide audience, ensuring that beginners and experts alike can grasp key ideas. His clear and engaging writing helps readers stay informed about the latest trends, developments, and innovations in the crypto space. Whether explaining blockchain technology, digital assets, or DeFi, Ishtiyaq breaks down complicated ideas into simple, digestible content. His goal is to help people navigate the fast-changing world of cryptocurrency with confidence, clarity, and a deeper understanding.

Robinhood Chain isn’t wasting time trying to prove its relevance. Just three weeks after launch, the Ethereum-compatible Layer 2 has already accumulated around $700 million in onchain assets, signaling that Robinhood’s push to bring traditional finance onchain is gaining early traction.

Built on Arbitrum technology, Robinhood Chain is designed as a permissionless network that combines crypto, tokenized equities, ETFs, and other real-world assets within a single ecosystem. Rather than building another isolated blockchain, the project aims to move trading activity directly onchain while keeping the user experience closely integrated with Robinhood’s existing platform.

Stablecoins Dominate Early Capital InflowsThe largest share of capital has flowed into stable assets. According to Entropy Advisors dune dashboard, $433 million of the $700 million in onchain assets consists of stablecoins, highlighting that liquidity providers have become early participants in the network. 

Meanwhile, roughly $500 million has already been deployed across DeFi protocols, suggesting users are actively putting capital to work instead of simply holding assets idle.

A significant portion of that liquidity approximately $204 million has been deposited into Morpho, earning an estimated 7% yield through Steakhouse Financial. Notably, Morpho is integrated directly into the Robinhood app, allowing users to access yield opportunities without separately using Robinhood Wallet.

Network Activity Continues Building MomentumBeyond capital inflows, network usage is also expanding. The dashboard shows 97 million cumulative successful transactions, excluding failed transactions, alongside 1.65 million cumulative active addresses.

Those figures suggest users are interacting consistently with the network rather than generating isolated bursts of activity.

At the same time, tokenized real-world assets (RWAs) on the network have reached $17.76 million, reinforcing Loading profile preview ‘s broader objective of bringing traditional financial assets onto blockchain infrastructure.

Robinhood Chain Pushes Its Onchain Strategy ForwardThree weeks isn’t enough time to judge the long-term success of any blockchain. Still, the early numbers indicate that Robinhood Chain has attracted meaningful liquidity, active users, and DeFi participation shortly after launch. If capital inflows, transaction activity, and tokenized asset adoption continue expanding together, the network could strengthen its position as Robinhood’s bridge between traditional finance and onchain markets.

Loading article prices

Story Ends Here

Trust with CoinPedia:CoinPedia has been delivering accurate and timely cryptocurrency and blockchain updates since 2017. All content is created by our expert panel of analysts and journalists, following strict Editorial Guidelines based on E-E-A-T (Experience, Expertise, Authoritativeness, Trustworthiness). Every article is fact-checked against reputable sources to ensure accuracy, transparency, and reliability. Our review policy guarantees unbiased evaluations when recommending exchanges, platforms, or tools. We strive to provide timely updates about everything crypto & blockchain, right from startups to industry majors.

Investment Disclaimer:All opinions and insights shared represent the author's own views on current market conditions. Please do your own research before making investment decisions. Neither the writer nor the publication assumes responsibility for your financial choices.

Sponsored and Advertisements:Sponsored content and affiliate links may appear on our site. Advertisements are marked clearly, and our editorial content remains entirely independent from our ad partners.

Read the Next News

Are ALOT, IRDM, ESI, SOLS Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, July 21, 2026

HomeStock IdeasLong IdeasTech 

SummaryWall Street now carries 18 Buy ratings, eight Holds, and no Sells, while management reaffirmed $355-365 million quarterly revenue guidance.PCIe 6 products already contribute more than one-third of revenue, while 36% non-GAAP operating margins demonstrate strong operating leverage.Analysts raised EPS estimates 21 times and revenue estimates 20 times without a single downward revision, supporting 82% 2026 revenue growth expectations.Astera is expanding beyond retimers into fabric switches, memory connectivity, and rack-scale infrastructure, strengthening its role inside Nvidia's AI ecosystem. kynny/iStock via Getty Images

My investment outlook on Astera Labs, Inc. (ALAB) is getting even more compelling since the market is slowly starting to move away from the topic of how much hyperscalers are going to invest

8.36K Followers

Analyst’s Disclosure: I/we have a beneficial long position in the shares of ALAB either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Space Exploration Technologies (SPCX +3.19%) continues to enthrall investors, but so far, it hasn't been the hit that many may have been expecting. As of this writing, SpaceX (as the company is also known) is 40% off its peak and well below both its $135 initial public offering (IPO) price and its $150 opening price on its first day of trading.

But what investors really want to know is what comes next: Is it a bargain at the current price, and could this be the right time to buy? What has happened to other mega-IPOs may shed some light on that question.

Not the stocks you're thinking of When you hear "mega-IPO," you might be thinking of today's biggest companies, like Apple, Nvidia, and Microsoft. But these companies went public decades ago, at much smaller sizes, before they were household names, and before the mega-IPO was a thing.

In today's world, it's hard to keep a great IPO a secret, and many companies have been waiting to go public until after they've gained status and popularity. Not only was SpaceX the biggest IPO ever, it was followed up only weeks later by the secondary listing of SK Hynix on the Nasdaq, which was the second-biggest initial offering ever and the biggest international IPO ever.

But some of the largest IPOs in history are companies you know about, and some of them have become some of the most valuable companies in the world. Consider Visa, Meta Platforms (which went public as Facebook), General Motors, and Rivian.

CompanyIPO ValueCurrent ValueShare Price Change After 1 MonthShare Price Change After 1 YearVisa$18 billion$676 billion22%(7)%Meta Platforms (Facebook)$16 billion$1.6 trillion(18)%(31)%General Motors$23 billion$69 billion0%(36)%Rivian$12 billion$22 billion15%(70)% Data source: YCharts, CNBC, Forbes.

As you can see, results for such debuts have been mixed. This is only a tiny sampling, and some of the other largest historical IPOs are companies that retail investors may not have heard of, like ENEL and Telstra (a point that doesn't bode well for large IPOs).

Can SpaceX bounce back? Big, splashy IPOs don't necessarily lead to big gains, at least not immediately. Other than SpaceX, the only large IPOs that have become megacap companies are Meta and Visa, which are the seventh- and 16th-most-valuable companies by market cap in the U.S., respectively.

Over time, most large IPO stocks have come back from their early declines, but few of them have been the kinds of stocks that have minted millionaires. SpaceX may rebound over time, but you're likely to find better buys among lower-key IPOs that have great fundamentals.

Jennifer Saibil has positions in Apple and Rivian Automotive. The Motley Fool has positions in and recommends Apple, Meta Platforms, Microsoft, Nvidia, Telstra Group, and Visa. The Motley Fool recommends General Motors. The Motley Fool has a disclosure policy.

The $25K Day Trading Barrier is Gone

The long-standing Pattern Day Trader (PDT) rule that required many traders to maintain a $25,000 account balance is no longer standing in the way.

That means more traders can actively pursue short-term opportunities without the barrier that kept so many on the sidelines.

Now it's all about having the right strategy.

Dynamite Day Trading Signals helps you hit the ground running with up 2 options trade alerts per week, built to capture fast-moving opportunities.  

👉 Sign up now to receive the next trade

Apple is raising prices on Apple Music subscriptions as well as certain Apple One plans as the company faces higher licensing costs.

The tech giant last week hiked prices for Apple Music plans across subscription tiers. Individual plans will rise by $1 a month to $11.99, while student plans will increase by the same amount to $6.99 a month.

Prices for the Apple Music family plan are also rising by $3 per month to a new monthly rate of $19.99.

The company also hiked prices for some tiers of Apple One – the company's bundle that allows consumers to subscribe simultaneously to Apple TV, Music, iCloud+, Arcade, Fitness+ and News+ or the first four services.

APPLE RAISES IPAD AND MACBOOK PRICES AS MEMORY CHIP COSTS SURGE

Apple raised prices on Apple Music plans as well as some Apple One packages. (CFOTO/Future Publishing via Getty Images)

Prices for the Apple One family tier are set to rise by $2 to a new total of $27.95 per month. Family plans may be shared with up to five people and have up to 200 gigabytes of iCloud storage, though they don't include News+ or Fitness+ in the package.

The individual Apple One subscription, which includes the same four services but with 50 gigabytes of iCloud storage, is unchanged at $19.95 a month.

Apple One's Premier package, which includes all six of the company's subscription services with up to 2 terabytes of storage and may be shared among five people, will rise in price by $2 to $39.95 per month.

APPLE BRIEFLY OVERTAKES NVIDIA AS WORLD'S MOST VALUABLE COMPANY AMID AI INVESTMENT DOUBTS

Ticker Security Last Change Change % AAPL APPLE INC. 327.74 +1.15 +0.35% The price increases apply to consumers in the U.S. as well as other countries around the world.

The moves weren't announced by Apple, which adjusted the prices for the various subscriptions and tiers on its website on Friday. Apple told 9to5Mac, "As a result of rising licensing costs, Apple Music is increasing its subscription price beginning today."

FOX Business reached out to Apple for comment.

APPLE HIT WITH LAWSUIT CLAIMING ICLOUD+ PRIVACY TOOL COULD EXPOSE USERS' REAL EMAILS TO WEBSITES

Apple's subscription price hikes follow higher iPad and MacBook prices. (Apple)

In late June, Apple announced price hikes for its iPad tablets and MacBook laptops amid rising memory chip costs.

The company raised the price of the MacBook Air by $200 to a new total of $1,299, while the budget Neo laptop price rose from $599 to $699. The price of a MacBook Pro with 1 terabyte of storage rose $300 to $1,999, while the iPad Air with 128 gigabytes of storage rose from $599 to $749.

GET FOX BUSINESS ON THE GO BY CLICKING HERE

Apple said at the time that it has "never seen a component price increase this much, this quickly," adding that it had "shielded our customers from these increases so far, but we have now reached a point where we need to begin raising prices on a number of products."

Here are the earnings estimates, what experts are saying ahead of the report and the key items to watch.

Tesla Q2 Earnings EstimatesAnalysts expect Tesla to report second-quarter revenue of $25.24 billion, up from $22.50 billion in last year’s second quarter, according to data from Benzinga Pro.

The company has beaten analyst estimates for revenue in four straight quarters and in five of the last 10 quarters overall.

Analysts expect Tesla to report second-quarter earnings per share of 44 cents, up from 40 cents per share in last year’s second quarter.

The company has beaten analyst estimates for earnings per share in two straight quarters and in four of the last 10 quarters overall.

What Experts Are SayingTesla investors are looking for second-quarter results to show signs of improvement with the stock one of the worst performing Magnificent Seven stocks in 2026, Freedom Capital Markets Chief Market Strategist Jay Woods said in a weekly newsletter.

"Shareholders are hopeful this quarter will be the one that helps turn things around. Shares have traded lower after three of the last four reports with an average loss of -5% over that time," Woods said.

The market expert says AI will be the top thing on the mind of Tesla investors for the earnings report.

"Will there be updates surrounding robotaxis, Full Self-Driving, Cybercab production, and the Optimus robot as Telsa continues its transition from an automaker to an AI and robotics story?"

For the automotive part of the business, Woods said investors should watch margins closely to see if they stabilize after pricing pressure in recent quarters and to see if the core segment can help produce the cash needed to fund growth initiatives.

Woods said one negative reaction to the earnings report could send the stock back to April lows around $340. If investors react positively, a nice pop could take shares to the resistance at the 200-day moving average around $417, Woods added.

"A strong rebound may hit major resistance near $420. Seeing it is one of Elon Musk’s favorite numbers, it may need to eclipse this mark before the strongest bullish case can be made to own shares."

Deepwater Management Managing Partner Gene Munster says investors will be watching for higher capex, automotive gross margins, an update on the robotaxi rollout and an update on the Cybercab production ramp.

"The bottom line is the long-term growth story is intact," Munster said in a blog post.

The market expert doesn’t expect any big updates on robotaxis, Cybercab, FSD or Optimus. Munster said he expects one minor update to be that Cybercab production ramp to shift from late 2026 to the first half of 2027.

"I believe Elon will reiterate that everything is moving in the right direction."

Here are recent analyst ratings on Tesla stock and their price targets:

GLJ Research: Reiterated Sell rating, price target $24.86 Morgan Stanley: Maintained Equal-Weight rating, raised price target from $415 to $417 Barclays: Maintained Equal-Weight rating, raised price target from $360 to $370 Wells Fargo: Maintained Underweight rating, raised price target from $125 to $130 Key Items to WatchTesla already reported second-quarter deliveries of 480,126 vehicles, up 25% year-over-year. The total beat a Street estimate of 406,000.

Munster previously attributed some of the outperformance to higher gas prices and increased demand for electric vehicles. Investors and analysts will be watching to see if management says this was the case and if it bodes well for future quarters with ongoing Middle East tension.

Munster’s guess that the Cybercab production ramp could be pushed back is an item to watch, as it could spook investors. Tesla previously said it was on track for "this year" for both Cybercab and Tesla Semi.

Investors also want an update on Optimus, which is said to be one of the company’s biggest catalysts ever and the reason why Tesla stopped selling several vehicle models to get factories ready for production.

Tesla Stock Price ActionTesla stock was up 2.5% to $378.93 on Tuesday versus a 52-week trading range of $297.82 to $498.82. Tesla stock is down 13.3% year-to-date in 2026, with shares near a three-month low.

Photo: TY Lim / Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.

, /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Alphabet Inc. ("Alphabet" or the "Company") (NASDAQ: GOOG) investors concerning the Company's possible violations of the federal securities laws.  

IF YOU ARE AN INVESTOR WHO LOST MONEY ON ALPHABET INC. (GOOG), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS.

What Happened? 
On July 16, 2026, Bloomberg news reported that Alphabet's Google is "months behind schedule on delivering Gemini 3.5 Pro, its most powerful flagship AI model" due to the Company's ongoing coding efforts. Specifically, "[l]ate last month, Google updated the data being used to train Gemini in an attempt to improve [its] skills, but the results were disappointing."

On this news, Alphabet's stock price fell $16.40, or 4.4%, to close at $353.81 per share on July 16, 2026, thereby injuring investors.

Contact Us To Participate or Learn More: 
If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us.
Charles Linehan, Esq.,
Glancy Prongay Wolke & Rotter LLP,
1925 Century Park East, Suite 2100,
Los Angeles California 90067
Email:  [email protected]
Telephone: 310-201-9150 (Toll-Free: 888-773-9224)
Visit our website at www.glancylaw.com.
Follow us for updates on LinkedIn, Twitter, or Facebook.

Whistleblower Notice
Persons with non-public information regarding Alphabet should consider their options to aid the investigation or take advantage of the SEC Whistleblower Program. Under the program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Charles H. Linehan at 310-201-9150 or 888-773-9224 or email [email protected].

About Glancy Prongay Wolke & Rotter LLP
GPWR is a premier law firm with decades of experience representing investors and consumers in securities litigation and other complex class action litigation. Recognizing the firm's recent successes, GPWR was named one of Law360's Securities Groups of the Year and ranked second-highest in total investor recoveries by Institutional Shareholder Services Securities Class Action Services in 2025. GPWR's lawyers have handled cases covering a wide spectrum of corporate misconduct and relating to nearly all industries and sectors. GPWR's past successes have been widely covered by leading news and industry publications such as The Wall Street Journal, The Financial Times, Bloomberg Businessweek, Reuters, the Associated Press, Barron's, Investor's Business Daily, Forbes, and Money. Prior results do not guarantee a similar outcome.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contact Us: 
Glancy Prongay Wolke & Rotter LLP,
1925 Century Park East, Suite 2100,
Los Angeles, CA 90067
Charles Linehan
Email:  [email protected]
Telephone: 310-201-9150
Toll-Free: 888-773-9224
Visit our website at: www.glancylaw.com.

SOURCE Glancy Prongay Wolke & Rotter LLP

HomeStock IdeasLong IdeasTech 

SummaryMicrosoft Corporation is shifting from seat-based software subscriptions to consumption-driven AI monetization across its ecosystem.MSFT’s record $190B capital expenditure is backed by confirmed demand, with Azure capacity still lagging customer needs and $627B in contracted obligations.Copilot and GitHub Copilot adoption is accelerating, with usage-based pricing driving scalable, recurring revenue and deepening enterprise integration.At 23x forward earnings and 15-21% projected EPS growth, MSFT’s risk/reward profile is highly attractive despite near-term margin pressure. tupungato/iStock Editorial via Getty Images

Microsoft Corporation's (MSFT) recent correction has been caused almost exclusively by fears of its record-breaking capital expenditures on AI. I think the market is making the same mistake it did during the initial Azure

616 Followers

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, but may initiate a beneficial Long position through a purchase of the stock, or the purchase of call options or similar derivatives in MSFT over the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

At the end of last year, Warren Buffett retired as chairman and CEO of Berkshire Hathaway (BRKA 0.15%)(BRKB 0.40%) and passed the reins to Greg Abel. Although Buffett still has some influence on the company, it's clear that Abel and Berkshire Hathaway are embracing new strategies.

Since Abel took over, Berkshire Hathaway's stock portfolio has changed a bit, and one of the biggest shifts is that it has loaded up on Alphabet (GOOG 1.46%)(GOOGL 1.39%). Berkshire Hathaway purchased its first Alphabet shares in late 2025, but Abel has taken it up a notch. It's now Berkshire Hathaway's fifth-largest holding, accounting for 8.7% of its stock portfolio (across both share classes).

Image source: The Motley Fool.

Alphabet isn't the typical Berkshire Hathaway investment, but amid the evolving artificial intelligence (AI) landscape, it makes sense for the conglomerate to embrace an AI company that has its hands in many pots. Between its prior public stake and the company's announcement of a new $10 billion private placement purchase in June, Berkshire Hathaway now holds a nearly $31 billion stake.

Today's Change

(

-1.39

%) $

-4.88

Current Price

$

347.11

Alphabet is becoming a one-stop AI shop It's clear that AI is here to stay. The way people and businesses interact with it will inevitably evolve, but the technology itself isn't going anywhere. Alphabet is a smart investment for Berkshire Hathaway because it's a full-stack AI company that handles most of the pipeline in-house. It has operations in key parts of the AI ecosystem, including:

Research: Google DeepMind. Hardware: Custom AI chips. Infrastructure: Google Cloud and data centers. Applications: Gemini, productivity apps, and AI Overviews. Alphabet still relies on other companies for certain hardware -- such as Nvidia for chips or Taiwan Semiconductor Manufacturing Company for manufacturing -- but it's slowly but surely reducing its reliance on third parties and heading toward vertical integration.

When you're too reliant on other companies, you're at the mercy of their pricing and supply, so Alphabet is putting itself in a position to control more of its own destiny.

Google Cloud is becoming one of Alphabet's most impressive businesses If you're considering adding AI companies to your portfolio, it makes sense to include one of the leading builders of cloud computing infrastructure. Google Cloud lags behind Amazon Web Services (AWS) and Microsoft's Azure in market share, but it's by far the fastest-growing major cloud provider.

In the first quarter, Google Cloud revenue jumped 63% year over year to $20 billion. AWS and Azure grew their revenues by 28% and 40%, respectively, in their most recently reported quarters.

Don't expect Google Cloud to catch up to AWS or Azure in terms of size anytime soon, but its relatively small size leaves it plenty of room for growth as the cloud computing market as a whole grows. Alphabet stock is a perfect way to invest in AI without throwing money into more volatile and speculative businesses.

It has cash flow that only a handful of companies can match, a virtual monopoly in online search, and not much of the risk that comes with cyclical tech businesses or newer companies.

Stefon Walters has positions in Microsoft and Taiwan Semiconductor Manufacturing. The Motley Fool has positions in and recommends Alphabet, Amazon, Berkshire Hathaway, Microsoft, Nvidia, and Taiwan Semiconductor Manufacturing. The Motley Fool has a disclosure policy.

Nvidia says its latest chip designs are making their way to customers and will help solidify the chipmaker's leadership in the industry. This as the company is under pressure to show that its latest products are on schedule and superior to rivals like AMD and Broadcom.

Key Takeaways NVIDIA could benefit as easing inflation supports AI spending and Blackwell platform deployments.Amazon reported strong retail and AWS growth, with management guiding for higher second-quarter sales.NVDA and AMZN are highlighted as growth stocks positioned to gain from a less restrictive rate environment. The cooler-than-expected June Consumer Price Index (CPI) report has increased expectations that inflationary pressures are gradually easing, improving the outlook for sectors that are highly sensitive to interest rates and consumer spending. U.S. headline CPI rose 3.5% year over year in June, down from 4.2% in May, while core CPI slowed to 2.6%, signaling continued moderation in underlying price pressures. The report also showed the first monthly decline in headline prices since 2020, reflecting softer energy costs and broad-based easing across several categories.

Fed Holds Rates Steady, Rate-Cut Hopes Gain MomentumWhile the Federal Reserve kept benchmark interest rates unchanged at its June policy meeting and reiterated that future decisions will remain data dependent, the latest inflation data has strengthened market expectations that the next policy move is more likely to be a rate cut than another hike if disinflation continues. Lower inflation also eases pressure on Treasury yields, improves financing conditions and supports equity valuations, particularly for sectors whose earnings and multiples are sensitive to borrowing costs.

Against this improving macro backdrop, two stocks that appear well positioned to benefit from easing inflation and the prospect of a less restrictive interest-rate environment are NVIDIA (NVDA - Free Report) from the technology sector and Amazon (AMZN - Free Report) from the consumer discretionary space.

Let’s get into more details.

Why Technology and Consumer Discretionary Stand to BenefitTechnology companies, particularly those tied to artificial intelligence, cloud computing and semiconductors, typically outperform when inflation moderates because lower interest-rate expectations increase the present value of future earnings and support premium valuations. At the same time, secular AI infrastructure spending by hyperscalers continues to provide a strong fundamental tailwind.

Consumer discretionary is another likely beneficiary. Cooling inflation improves consumers' purchasing power by reducing pressure on household budgets, while easing energy prices leave more disposable income available for discretionary purchases. Combined with a resilient labor market and steady wage growth, this environment could support higher spending across retail, travel, restaurants and leisure businesses.

Although policymakers continue to caution that inflation remains above the Federal Reserve's 2% target and additional data will determine the policy path, the June CPI report marks an important step toward a more favorable macro environment for growth- and consumption-oriented sectors.

Our PicksNVIDIA: Its momentum continues to be driven by unprecedented demand for its Blackwell AI platform from hyperscalers, enterprises and sovereign AI projects. NVIDIA's latest guidance points to another quarter of robust revenue growth, supported by continued AI infrastructure investments despite export-related headwinds. As financing conditions improve, sustained enterprise AI spending and accelerating Blackwell deployments should support NVIDIA's near-term growth trajectory.

This Zacks Rank #1 (Strong Buy) stock has seen the Zacks Consensus Estimate for fiscal 2027 earnings increase by 11% over the past 60 days, reflecting analysts' growing confidence in sustained AI demand and Blackwell deployments. The full-year estimate of $9.09 indicates 90.6% growth over the fiscal 2026 reported number. You can see the complete list of today’s Zacks #1 Rank stocks here.

Image Source: Zacks Investment Research

Amazon: Amazon too is well positioned to benefit from easing inflation through both its consumer-facing retail operations and Amazon Web Services (AWS). Cooling price pressures could strengthen discretionary spending, while lower borrowing costs encourage enterprise cloud and AI investments. In first-quarter 2026, Amazon reported a 17% year-over-year increase in net sales with AWS revenues rising 28% year over year. Management guided second-quarter net sales of $194-$199 billion, reflecting confidence in continued demand across both retail and cloud businesses.

This Zacks Rank #2 (Buy) stock has seen the Zacks Consensus Estimate for 2026 earnings increase by 15% over the past 90 days, supported by AWS growth, advertising strength and improving retail margins. The full-year estimate of $8.93 indicates 24.6% growth over the 2025 reported number.

Image Source: Zacks Investment Research

Key Takeaways Alphabet and Tesla are slated to report Q2 earnings Wednesday afternoon, kicking off what’s expected to be another round of strong reports for the Magnificent Seven.The Mag 7 stocks have underperformed the S&P 500 this year amid uncertainty about the return on their AI investments. Get personalized, AI-powered answers built on 27+ years of trusted expertise.

The Magnificent Seven stocks may be more “Lag 7” than “Mag 7” this year, but their profits are still pretty magnificent.

The Mag 7—Nvidia (NVDA), Alphabet (GOOG), Apple (AAPL), Microsoft (MSFT), Amazon (AMZN), Meta (META), and Tesla (TSLA)—have grown faster than the rest of the S&P 500—or the “Other 493”—in every quarter since the end of 2022, and estimates suggest that was likely the case last quarter, too. In the coming weeks, the Mag 7 are expected to report earnings grew about 31% in the second quarter, a slowdown from 63% in Q1 but still ahead of the Other 493’s 23% growth.1  

Tesla and Google-parent Alphabet will be the first of the group to post Q2 results when they report after the bell Wednesday. Analysts expect the search and cloud computing giant had another strong quarter, with revenue projected to increase about 20%, driven by a 65% increase in cloud revenue. The report will set expectations for cloud computing competitors and fellow Mag 7 members Microsoft and Amazon, both of which are slated to report next week. 

Why This Is Important to Investors The Magnificent Seven earned their nickname in 2023 when their earnings and stocks soared as the economy and the rest of the stock market struggled. The tables have turned in the stock market this year, but the tech giants have continued to grow faster than most of the S&P 500.

Mag 7 stocks accounted for the vast majority of the S&P 500’s rise in recent years, but the group has lagged the broader market in 2026 amid uncertainty about the return on their huge AI investments. The Roundhill Magnificent Seven ETF (MAGS) is up less than 2% since the start of the year, trailing the S&P 500’s nearly 10% return. 

The combination of stock weakness and earnings strength has many of the Mag 7 stocks trading at relatively undemanding valuations. “I don’t think there’s a problem paying 24 times forward earnings for a company that can grow high-margin revenue at roughly 20%,” said David Miller, CIO at Catalyst Funds, of Alphabet on Tuesday. “From a price-to-earnings-growth perspective, those numbers work.”

But the Mag 7’s earnings growth may not be Wall Street’s focus when they report in the coming weeks. Revenue and earnings “are likely to not matter as much as the amount of capital spending completed in the quarter and the guide for the rest of the year,” wrote Wolfe Research analysts on Tuesday.2 The hyperscalers—Alphabet, Microsoft, Amazon, Meta, and Oracle (ORCL)—reported strong results across the board last quarter, but their stocks mostly languished as investors focused on capex increases. 

Hyperscalers are expected to spend upwards of $700 billion on capital expenditures this year, and much of that total is earmarked for AI data centers. Those investments have caused their free cash flows to dwindle, and compelled several of them to tap debt and equity markets for fresh capital, increasing their exposure to fluctuating interest rates. 

Wolfe Research expects the hyperscalers in aggregate to increase their capex guidance again in the coming weeks.3 While that may pressure their stocks, it could reinvigorate the shares of semiconductor, memory and data storage suppliers, whose sales and earnings growth have been turbocharged by the AI data center buildout. After a torrid rally throughout the second quarter, memory and chip stocks have cooled off in recent weeks. Some market watchers say that’s created opportunities to own stocks expected to benefit from AI spending for years to come. 

“Nvidia is trading like a value stock,” said Nancy Tengler, CEO of Laffer Tengler Investments, on Tuesday. “You have to believe all the [AI] spending is going to stop tomorrow” to justify the stock’s forward price-to-earnings ratio of about 16x, said Tengler. 

Organic Growth: 5.4% in Q2.Operating Margin: 24.9%, up 40 basis points.Earnings Per Share (EPS): $2.40, up 11%.Free Cash Flow: $1.3 billion with 107% conversio

Netflix gave streaming investors a jolt last week. The industry leader reported second-quarter results that were fine on their own, but its forecast called for revenue growth to slow again in the third quarter, and the stock, already deep in a yearlong slide, fell further on Friday.

Walt Disney (DIS 0.31%) shareholders know the feeling. Shares of the entertainment giant have fallen about 15% in 2026, to roughly $96 as of this writing, and they trade about 22% off their 52-week high.

But there's an irony in the timing. While the market frets over the streaming leader's slowing growth, Disney's own streaming business has been moving the other direction -- toward faster growth and higher profits.

So, with the leader stumbling, is the House of Mouse the contrarian buy in streaming?

Image source: Walt Disney.

Behind the decline Disney's sell-off this year wasn't baseless. In the company's fiscal first quarter of 2026 (the period ended Dec. 27, 2025), total segment operating income fell 9% year over year. The biggest problem was the entertainment segment, where operating income dropped 35% to $1.1 billion as programming, production, and marketing costs grew faster than revenue. The sports segment's operating income fell 23%, too, dinged by about $110 million from YouTube TV temporarily dropping Disney's networks in a carriage dispute.

Layer on the long-running decline of linear television and management's own caution about consumers (Disney says it is "mindful of the macroeconomic uncertainty consumers are facing today"), and investors had reasons to sour on the stock.

Streaming profits are finally showing up But the fiscal second quarter (ended March 28, 2026) showed a company in better shape than the stock price suggests. Revenue increased 7% year over year to $25.2 billion, and total segment operating income grew 4%. Non-GAAP (adjusted) earnings per share rose 8% to $1.57.

Streaming was the standout. Disney's subscription streaming revenue grew 13% year over year, accelerating from 11% growth in fiscal Q1, with subscription fees up 16%. And the streaming business's operating income nearly doubled year over year, climbing from $310 million to $582 million. That works out to a streaming operating margin of about 11%, up from about 6% a year earlier.

The trend within the year matters as much as the comparison. Streaming operating income went from $450 million in the fiscal first quarter to $582 million in the second, and the margin stepped up alongside it.

And Disney's content engine is helping. Zootopia 2 generated $1.9 billion at the global box office, and the franchise has since surpassed 1 billion hours streamed on Disney+. Hits like that can feed the company's parks and merchandise businesses for years to come.

The parks themselves are holding up as well. Experiences revenue rose 7% in the fiscal second quarter, and the segment's operating income grew 5%. Management called current demand at its domestic parks healthy, and it expects attendance to improve in fiscal Q3 after a 1% dip in the March quarter tied partly to soft international visitation.

Put it together, and management expects fiscal 2026 adjusted earnings per share to grow about 12%, excluding the benefit of an extra week in the fiscal year. The company is also targeting at least $8 billion in share repurchases in fiscal 2026.

Today's Change

(

-0.31

%) $

-0.30

Current Price

$

96.11

Yet the stock trades at about 13 times forward earnings. That's about two-thirds of what investors are paying for Netflix's forward earnings -- for the streaming business that's accelerating, not the one that's slowing down.

Of course, Disney's cheaper multiple partly reflects its baggage. The decline of linear TV remains a headwind, and those networks still generate profits that streaming must replace. A weakening consumer could hit the parks, which remain Disney's biggest source of operating income. And film slates are hit-driven, so the box office may disappoint in any given quarter.

With that said, the market seems to be pricing Disney as if its streaming turnaround isn't happening, even as the numbers show that turnaround gaining speed. To me, that makes Disney the more interesting streaming stock today -- a profitable, diversified entertainment company at 13 times forward earnings, backed by guided double-digit earnings growth and a large buyback program.

In short, I think the pessimism has overshot, and Disney looks like a contrarian buy here. Though I'd start with a modest position. With all of this said, we'll find out more soon; Disney's fiscal third-quarter report is due in early August.

Revenue: $92 billion in the first half of 2026; $48 billion in Q2 2026, up $900 million year-over-year.EBIT Adjusted: $8.2 billion in the first half of 2026; $

Goldman Sachs logo appears in this illustration taken December 1, 2025. REUTERS/Dado Ruvic//File Photo Purchase Licensing Rights, opens new tab

CompaniesJuly 21 (Reuters) - Goldman Sachs (GS.N), opens new tab has created a new platform as it looks to expand its private market offerings for wealthy clients, according to ​an internal memo seen by Reuters on Tuesday.

The alternative ‌investment platform will be led by Matt Doherty, who will continue to oversee the Wall Street bank's alternatives business, the memo said.

Jumpstart your morning with the latest legal news delivered straight to your inbox from The Daily Docket newsletter. Sign up here.

The move comes as wealthy ​investors increasingly seek access to privately held companies, where many ​fast-growing startups are staying private for longer, allowing investors ⁠to benefit from rising valuations before an initial public offering.

Companies such ​as Elon Musk's SpaceX (SPCX.O), opens new tab remained privately held for years before going public ​last month even as its valuation surged, fueling demand among wealthy investors for private market investments. The AI boom has only bolstered that interest.

That has prompted ​Wall Street banks to expand their private market offerings for wealthy ​clients.

Alternative capital markets, which manage alternative investments for wealthy clients, will remain the ‌core ⁠business within the platform, the memo showed.

The team will continue to help clients invest in private market assets, advise them on building alternative investment portfolios and manage those portfolios on their behalf.

As part of ​the changes, Goldman ​is creating a ⁠new private company investments team by combining its fiduciary single-asset investment business with its family office-focused direct ​investment business.

The changes are intended to build on the ​growth ⁠of Goldman Sachs' alternatives business and strengthen its private markets platform.

CNBC had reported the news earlier in the day.

Earlier this month, Goldman Sachs exceeded second-quarter ⁠profit ​expectations as dealmaking picked up and market ​volatility amid the U.S.-Iran war boosted equities revenue to a record.

Reporting by Prakhar Srivastava ​in Bengaluru and Saeed Azhar in New York; Editing by Shilpi Majumdar

Our Standards: The Thomson Reuters Trust Principles., opens new tab